Role of Fetuin-A in Tumor Cell Growth
胎球蛋白-A 在肿瘤细胞生长中的作用
基本信息
- 批准号:7497495
- 负责人:
- 金额:$ 36.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-19 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseA MouseAcidsAddressAffectAmino Acid SequenceAnimalsAnnexinsAreaBackBindingBiologicalBrainBreast CarcinomaCalciumCell CommunicationCell Surface ReceptorsCell surfaceCellsCellular biologyCodeComplexConditionConfocal MicroscopyControl AnimalCulture MediaDataDrug DesignEligibility DeterminationEsophagealGalectin 3GenesGlycoproteinsGoalsGrowthGrowth FactorIn VitroIonsKnockout MiceLNCaPLectinLiverLocalizedLungMalignant Epithelial CellMalignant neoplasm of prostateMammary NeoplasmsMediatingNamesNational Institute of General Medical SciencesNeoplasm MetastasisNumbersPC3 cell linePancreasPathway interactionsPharmaceutical PreparationsPhosphoinositide-3-Kinase, Catalytic, Gamma PolypeptidePhosphorylationPhosphotransferasesReadingResistanceRoleSerumSerum ProteinsSialic AcidsSignal PathwaySignal TransductionSignal Transduction PathwaySignaling MoleculeSkinSpecificitySurfaceTechniquesTestingTransferrinTransforming Growth Factor betaWeekWorkalpha-Fetoproteinsbasecancer cellcancer typecell growthfrontiergrowth promoting activityin vivoinhibitor/antagonistinnovationknock-downlung Carcinomaneoplastic cellreceptorsugartumortumor growthtumor progression
项目摘要
DESCRIPTION (provided by applicant): Our long-term objectives are to elucidate the mechanisms by which fetuin-A, a serum glycoprotein synthesized by the liver, mediates and regulates the in vitro and in vivo growth of tumor cells. The central hypothesis is that fetuin-A derived from the serum or synthesized by the tumor cells interacts with its putative cell surface receptors, triggering PI3 kinase/Akt signaling that drives the growth of the cells. The hypothesis will be investigated through 4 specific aims: (1) To define the cell surface receptors for fetuin-A in tumor cells responsible for growth signaling; (2) To determine other signaling pathways which are modulated in tumor cells by the annexin/fetuin-A interaction; (3) To elucidate the role of ectopically synthesized fetuin-A in tumor cell growth; and (4) To define the specificity of serum derived fetuin-A in tumor growth promotion.
In aim 1, we will extend our studies that were done on a limited scale using LLC cells to LNCaP prostate cancer cell line transfected with annexin-2-GFP. The co-localization and interaction between annexin-2 and fetuin-A in these cells will be studied using confocal microscopy. It is expected that annexins will emerge as the cell surface receptors for fetuin-A responsible for growth signaling. In aim 2, Kinexus and Affymetrix gene arrays will be used to screen for other signaling molecules whose expression is affected by the fetuin-A/annexin interaction. A number of signaling pathways cross-talk with the PI3 kinase/Akt pathway that is predominantly activated by fetuin-A. In aim 3, fetuin-A gene will be added back to cells that do not express it to determine if this is sufficient to allow these cells to grow under serum-free conditions and in fetuin-A null mice. Likewise, fetuin-A expression in LLC cells will be knocked down by sh-RNA approach and their growth under serum-free conditions re-evaluated. In aim 4, the serum from fetuin-A wild-type animals will be used to supplement growth medium to determine its growth promoting abilities in a variety of tumor cells vis-a-vis growth medium supplemented with serum from fetuin-A null mice. In this aim, we will determine whether the unique ability of fetuin-A to promote cell growth is also dictated by its amino acid sequence and not merely the presence of sialic acid residues. This proposal seeks to demonstrate that fetuin-A is an important fuel for the in vivo growth of tumor cells and is not an innocent bystander. The full understanding of this pathway has broad implications in the management and treatment strategies for majority of cancer types.
描述(由申请人提供):我们的长期目标是阐明胎儿素a(一种由肝脏合成的血清糖蛋白)介导和调节肿瘤细胞在体内和体外生长的机制。核心假设是来自血清或由肿瘤细胞合成的胎蛋白a与其假定的细胞表面受体相互作用,触发PI3激酶/Akt信号,驱动细胞生长。这一假设将通过以下四个特定目的进行研究:(1)确定肿瘤细胞中负责生长信号传导的胎蛋白a的细胞表面受体;(2)确定膜联蛋白/胎蛋白a相互作用在肿瘤细胞中调节的其他信号通路;(3)阐明异位合成胎蛋白a在肿瘤细胞生长中的作用;(4)明确血清源性胎蛋白a促进肿瘤生长的特异性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSIAH OCHIENG其他文献
JOSIAH OCHIENG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSIAH OCHIENG', 18)}}的其他基金
Analysis of Serum Exsomes in Patients with Colorectal and Breast Cancer
结直肠癌和乳腺癌患者血清外泌体分析
- 批准号:
8261513 - 财政年份:2011
- 资助金额:
$ 36.63万 - 项目类别:
INTEGRIN ACTIVITIES DURING TUMOR PROGRESSION BY GALECTIN-3
Galectin-3 在肿瘤进展过程中的整合素活性
- 批准号:
6485272 - 财政年份:2001
- 资助金额:
$ 36.63万 - 项目类别:
相似海外基金
Disentangling Genetic and Experiential Risk Factors for Cortical Abnormalities in a Mouse Model of Schizophrenia
解开精神分裂症小鼠模型皮质异常的遗传和经验危险因素
- 批准号:
MR/Y014693/1 - 财政年份:2024
- 资助金额:
$ 36.63万 - 项目类别:
Research Grant
Recruitment of Cerebellar Circuits with Balance Training for Cognitive Rehabilitation in a Mouse Model of Mild Traumatic Brain Injury
在轻度创伤性脑损伤小鼠模型中通过平衡训练募集小脑回路进行认知康复
- 批准号:
10753349 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
- 批准号:
10589192 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Analysis of molecular mechanisms of kidney cancer development by epigenetic mutations in a mouse model.
通过小鼠模型的表观遗传突变分析肾癌发生的分子机制。
- 批准号:
23K15771 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A mouse model of relapsing polychondritis by utilizing matrilin-1 peptides
利用 matrilin-1 肽建立复发性多软骨炎小鼠模型
- 批准号:
23K05618 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cellular and circuit function of Ndnf-expressing interneurons in a mouse model of a neurodevelopmental disorder
神经发育障碍小鼠模型中表达 Ndnf 的中间神经元的细胞和回路功能
- 批准号:
10678812 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
A Mouse Model to Test the Effects of Gender-affirming Hormone Therapy on HIV Vaccine-induced Immune Responses
测试性别肯定激素疗法对 HIV 疫苗诱导的免疫反应影响的小鼠模型
- 批准号:
10748892 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
- 批准号:
23K08467 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deconstructing epileptic circuits in a mouse model of SLC6A1 syndrome
解构 SLC6A1 综合征小鼠模型中的癫痫回路
- 批准号:
10508480 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别: